119.03MMarket Cap-6320P/E (TTM)
4.020High3.720Low29.91KVolume3.960Open3.750Pre Close116.57KTurnover0.18%Turnover RatioLossP/E (Static)29.61MShares20.72052wk High39.41P/B66.51MFloat Cap3.51052wk Low--Dividend TTM16.54MShs Float20.720Historical High--Div YieldTTM8.00%Amplitude3.510Historical Low3.897Avg Price1Lot Size
Telomir Pharmaceuticals Stock Forum
NEWS
Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.
Telomir Pharmaceuticals presents promising pre-clinical data on Telomir-1 at a National Press Club event, showcasing a 40% increase in telomerase activity and lengthening of telomeres in human cells. The company plans to initiate human clinical trials for osteoarthritis and veterinary trials in 2025 after pre-clinical...
No comment yet